Hence, the NIHSS may underestimate stroke severity in the right hemisphere (Woo et al., 1999). In addition, although many components of the NIHSS are part of a standard neurological assessment ...
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara to treat large ...
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
A new study found that high blood pressure, atrial fibrillation, and smoking significantly increase stroke risk and severity.